BACKGROUND: The food supply is suspected to be a source of fluoroquinolone-resistant Escherichia coli that cause disease in humans, but supporting molecular data are lacking. METHODS: We performed a molecular-epidemiological comparison, in Barcelona, Spain (1996-1998), of 117 contemporaneous, geographically matched E. coli isolates from humans (35 blood isolates and 33 fecal) or chickens (49 fecal) that were either susceptible (n = 57) or resistant (n = 60) to ciprofloxacin and analyzed them by phylogenetic group, virulence genotype, and O antigens using random amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis (PFGE). RESULTS: When analyzed by phylogenetic distribution, virulence profiles, and O antigens, resistant human isolates were distinct from susceptible human isolates but were largely indistinguishable from chicken isolates, whereas resistant and susceptible chicken isolates were similar. Susceptible human isolates contained more virulence-associated genes and more frequently expressed virulence-associated O antigens than did resistant human or any chicken isolates. Certain resistant human isolates closely resembled chicken isolates by RAPD and PFGE analysis. CONCLUSIONS: Ciprofloxacin-resistant E. coli may arise de novo in poultry from susceptible progenitors, be transmitted to humans via the food supply, and go on to cause potentially life-threatening infections. If confirmed, these findings would mandate efforts to eliminate this reservoir of drug-resistant pathogens and/or to block their transmission to humans.
BACKGROUND: The food supply is suspected to be a source of fluoroquinolone-resistant Escherichia coli that cause disease in humans, but supporting molecular data are lacking. METHODS: We performed a molecular-epidemiological comparison, in Barcelona, Spain (1996-1998), of 117 contemporaneous, geographically matched E. coli isolates from humans (35 blood isolates and 33 fecal) or chickens (49 fecal) that were either susceptible (n = 57) or resistant (n = 60) to ciprofloxacin and analyzed them by phylogenetic group, virulence genotype, and O antigens using random amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis (PFGE). RESULTS: When analyzed by phylogenetic distribution, virulence profiles, and O antigens, resistant human isolates were distinct from susceptible human isolates but were largely indistinguishable from chicken isolates, whereas resistant and susceptible chicken isolates were similar. Susceptible human isolates contained more virulence-associated genes and more frequently expressed virulence-associated O antigens than did resistant human or any chicken isolates. Certain resistant human isolates closely resembled chicken isolates by RAPD and PFGE analysis. CONCLUSIONS:Ciprofloxacin-resistant E. coli may arise de novo in poultry from susceptible progenitors, be transmitted to humans via the food supply, and go on to cause potentially life-threatening infections. If confirmed, these findings would mandate efforts to eliminate this reservoir of drug-resistant pathogens and/or to block their transmission to humans.
Authors: James R Johnson; Stephen B Porter; Brian Johnston; Paul Thuras; Sarah Clock; Michael Crupain; Urvashi Rangan Journal: Appl Environ Microbiol Date: 2017-03-02 Impact factor: 4.792
Authors: L Jakobsen; P Garneau; G Bruant; J Harel; S S Olsen; L J Porsbo; A M Hammerum; N Frimodt-Møller Journal: Eur J Clin Microbiol Infect Dis Date: 2011-10-28 Impact factor: 3.267
Authors: Elizabeth Lyon Hannah; James R Johnson; Frederick Angulo; Bassam Haddadin; Jacquelyn Williamson; Matthew H Samore Journal: Foodborne Pathog Dis Date: 2009-04 Impact factor: 3.171
Authors: James R Johnson; Mark R Sannes; Cynthia Croy; Brian Johnston; Connie Clabots; Michael A Kuskowski; Jeff Bender; Kirk E Smith; Patricia L Winokur; Edward A Belongia Journal: Emerg Infect Dis Date: 2007-06 Impact factor: 6.883
Authors: Caroline Vincent; Patrick Boerlin; Danielle Daignault; Charles M Dozois; Lucie Dutil; Chrissi Galanakis; Richard J Reid-Smith; Pierre Paul Tellier; Patricia A Tellis; Kim Ziebell; Amee R Manges Journal: Emerg Infect Dis Date: 2010-01 Impact factor: 6.883